Tarsus Pharmaceuticals Inc. share price logo

Tarsus Pharmaceuticals Inc.

NASDAQ: TARS

Mid Cap

$58.14

-6.00

(-9.35%)

as on

Tarsus Pharmaceuticals Inc. Stock Performance

as on July 11, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $57.51
    $63.84
    downward going graph

    1.08%

    Downside

    9.80%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $38.51
    $85.25
    downward going graph

    33.76%

    Downside

    46.63%

    Upside

    downward going graph

Tarsus Pharmaceuticals Inc. share price movements today

Previous Close
$64.14
Open
$63.81
Volume
2.6M
Day's Low - High
$57.51 - $63.84
52 Week Low - High
$38.51 - $85.25

Tarsus Pharmaceuticals Inc. Historical Returns

1 Month Return
-7.14 %
3 Month Return
-19.87 %
1 Year Return
+ 48.39 %
3 Year Return
+ 232.04 %
5 Year Return
+ 98.97 %

Tarsus Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Tarsus Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8B

EPS (TTM)

-0.8229

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-49.0M

Revenue (TTM)

535.1M

Profit Margin

-9.02%

Return On Equity TTM

-13.96%

Tarsus Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tarsus Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Tarsus Pharmaceuticals Inc. image
Tarsus Pharmaceuticals Inc.
BUY$2.8B98.97%NA-9.02%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$41.8B69.04%81.2412.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.0B144.95%29.5935.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$70.0B14.49%16.1829.65%0.54%

Stock Returns calculator for Tarsus Pharmaceuticals Inc. Stock including INR - Dollar returns

The Tarsus Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tarsus Pharmaceuticals Inc. investment value today

Current value as on today

₹1,65,079

Returns

₹65,079

(+65.08%)

Returns from Tarsus Pharmaceuticals Inc. Stock

₹48,392 (+48.39%)

Dollar Impact

₹16,687 (+16.69%)

Analyst Recommendation on Tarsus Pharmaceuticals Inc. Stock

Based on 15 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Tarsus Pharmaceuticals Inc.. Average target price of $94.56

Tarsus Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Tarsus Pharmaceuticals Inc..

What analysts predicted

38.52%UPSIDE

Target Price

$94.56

Current Price

$58.14

Analyzed by

15 Analysts

Target

$94.56

Tarsus Pharmaceuticals Inc. target price $94.56, a slight upside of 38.52% compared to current price of $58.14. According to 15 analysts rating.

Indian Investors' Interest in Tarsus Pharmaceuticals Inc. Stock

Search interest for Tarsus Pharmaceuticals Inc. Stock has increased by 130% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:130% versus previous 30 day period

Tarsus Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
13
27
40
48
66
78
102
118
151
162
Gross Profit
11
25
37
44
61
73
96
94
140
152
Operating Income
-44
-37
-33
-25
-24
-26
-22
-14
-7
-6
EBITDA
-40
-34
-30
-20
-20
-22
-17
-12
-3
-6
Interest Expense
0
0
2
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-41
-35
-33
-23
-23
-25
-20
-12
-6
-9
Income Tax Expense
30
0
-
-
-
-
-
-
2
-2
Net Income
-41
-35
-33
-23
-23
-25
-20
-12
-8
-6
Net Profit Margin
-320.45%
-129.39%
-81.57%
-48.67%
-34.80%
-32.07%
-19.81%
-10.60%
-5.52%
-4.30%

Tarsus Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
33
57
25
17
182
451
Gross Profit
0
0
0
54
24
15
170
420
Operating Income
-1
-4
-26
-12
-62
-143
-120
-70
EBITDA
-1
-4
-26
-13
-59
-131
-106
-53
Interest Expense
-
0
0
2
2
3
7
8
Depreciation
0
0
0
0
0
0
1
1
Income Before Tax
-1
-4
-26
-13
-62
-135
-115
-64
Income Tax Expense
0
0
0
0
0
0
-
2
Net Income
-1
-4
-26
-13
-62
-135
-115
-66
Net Profit Margin
0.00%
0.00%
-80.20%
-24.25%
-240.51%
-778.89%
-63.16%
-14.72%

Tarsus Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-35
-33
-23
-23
-25
-20
-12
-8
-6
Operating Cash Flow
-37
-14
-8
-22
-20
-29
18
19
-24
Investing Cash Flow
-102
-40
3
-59
-34
-51
-4
49
-58
Financing Cash Flow
108
42
0
2
136
1
2
2
1
Change in Cash
-31
-12
-4
-78
80
-79
16
70
-82

Tarsus Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-26
-13
-62
-135
-115
-66
Operating Cash Flow
-3
-21
3
-49
-117
-83
-12
Investing Cash Flow
0
0
0
-144
140
-199
-42
Financing Cash Flow
59
131
0
93
130
154
143
Change in Cash
55
110
3
-99
153
-127
88

Global Institutional Holdings in Tarsus Pharmaceuticals Inc.

Funds
Holdings
RTW INVESTMENTS, LLC
7.78%
Assenagon Asset Management SA
2.98%
FMR Inc
1.7%
Delaware Management Holdings Inc
1.36%
Amvescap Plc.
1.73%
See all

Insights on Tarsus Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TARS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, TARS stock has moved up by 259.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TARS has outperformed top 5 stocks with highest market-cap in its industry

About Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
OrganisationTarsus Pharmaceuticals Inc.
Headquarters17700 Laguna Canyon Road, Irvine, CA, United States, 92618
IndustryBiotechnology
CEODr. Bobak R. Azamian M.D.
E-voting on sharesClick here to vote

Key Management of Tarsus Pharmaceuticals Inc.

Name

Title

Mr. Aziz Mottiwala M.B.A.

Chief Commercial Officer

Mr. Matthew Rossen M.B.A.

Vice President of Marketing

Mr. Scott Youmans

Vice President of Sales

Ms. Cara Miller

Senior Vice President of Corporate Affairs

Dr. Seshadri Neervannan Ph.D.

Chief Operating Officer

Dr. Bryan Wahl J.D., M.D.

General Counsel & Corporate Secretary

Ms. Dianne C. Whitfield M.S.W.

Chief Human Resources Officer

Ms. Neera Clase

Senior Vice President of Market Access

Dr. Bobak R. Azamian M.D.

Co-Founder, President, CEO & Chairman

Mr. David Nakasone

Head of Investor Relations

FAQs

What is Tarsus Pharmaceuticals Inc. share price today?

Tarsus Pharmaceuticals Inc. share price today is $58.14 as on at the close of the market. Tarsus Pharmaceuticals Inc. share today touched a day high of $63.84 and a low of $57.51.

What is the 52 week high and 52 week low for Tarsus Pharmaceuticals Inc. share?

Tarsus Pharmaceuticals Inc. share touched a 52 week high of $85.25 on and a 52 week low of $38.51 on . Tarsus Pharmaceuticals Inc. stock price today i.e. is closed at $58.14,which is 31.80% down from its 52 week high and 50.97% up from its 52 week low.

What is Tarsus Pharmaceuticals Inc.'s market capitalisation today?

Tarsus Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Tarsus Pharmaceuticals Inc. Stock (TARS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tarsus Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tarsus Pharmaceuticals Inc. Shares that will get you 0.0258 shares as per Tarsus Pharmaceuticals Inc. share price of $58.14 per share as on July 11, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tarsus Pharmaceuticals Inc. Stock (TARS) from India?

Indian investors can start investing in Tarsus Pharmaceuticals Inc. (TARS) shares with as little as ₹95.315 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.15 in Tarsus Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Tarsus Pharmaceuticals Inc. share’s latest price of $58.14 as on July 11, 2026 at 8:46 am IST, you will get 0.1720 shares of Tarsus Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Tarsus Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Tarsus Pharmaceuticals Inc. stock has given 98.97% share price returns and 28.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?